Stem Cell Therapeutic and Research Reauthorization Act of 2025

This bill renews the national program that helps patients find and receive life‑saving blood and marrow transplants. It continues federal support for the C.W. Bill Young Cell Transplantation Program and keeps building and maintaining the public cord blood supply, which helps patients who need a match for treatment of cancers, blood disorders, and other serious illnesses.

It also sets new funding levels for the program, including $31,009,000 in one year and $33,009,000 each year from 2027 through 2031. It updates rules for the national cord blood inventory to keep it strong and ready for patients in need.

• Who is affected: Patients needing blood or marrow transplants; families who donate cord blood; hospitals and transplant centers that search for matches.
• What changes: Continued funding for the national donor and transplant program and updates to the public cord blood inventory.
• When: Includes yearly funding amounts through 2031, with $33,009,000 set for each year from 2027 to 2031.